Skip to main content
. 2021 Jun 4;8(3):252–256. doi: 10.1016/j.ijnss.2021.05.005

Table 1.

Patient characteristics (n = 563).

Characteristics Group 1 (n = 133) Group 2 (n = 350) Group 3 (n = 80) χ2 P
Gender 1.74 0.42
 Male 70 (52.63) 164 (46.86) 42 (52.50)
 Female 63 (47.37) 186 (53.14) 38 (47.50)
Age, years 54 (18, 81) 56 (18, 78) 58 (28, 77) 6.08a 0.05
Marital status 5.68 0.46
 Single 10 (7.51) 22 (6.29) 2 (2.50)
 Married 117 (87.97) 321 (91.71) 76 (95.00)
 Divorced 3 (2.26) 2 (0.57) 1 (1.25)
 Widowed 3 (2.26) 5 (1.43) 1 (1.25)
Education level 8.98 0.18
 College 19 (14.29) 73 (20.86) 14 (17.5)
 Middle school 55 (41.35) 146 (41.71) 43 (53.75)
 Primary school 49 (36.84) 116 (33.14) 20 (25.00)
 Illiterate 10 (7.52) 15 (4.29) 3 (3.75)
Medical insurance 3.84 0.15
 Yes 100 (75.19) 291 (83.14) 64 (80.00)
 No 33 (24.81) 59 (16.86) 16 (20.00)
TIVAP indwelling duration, months 14 (10, 20) 16 (11, 24) 13.5 (10, 27) 8.26a 0.01
TIVAP insertion site 1.59 0.45
 Right internal jugular vein 115 (86.46) 291 (83.14) 64 (80.00)
 Left internal jugular vein 18 (13.54) 59 (16.86) 16 (20.00)
Flushing interval, days 28 (14, 29) 33 (30, 44) 57 (35, 215) 1075.72a <0.01

Note: Data are n (%), or Median (P25, P75). a Kruskal-Wallis H test. TIVAP = totally implantable venous access port.